PAINCHEK LTD (PCK)

---

AI Coverage Rating: Active

ASX AI Signals has generated 4 signal for PCK during the last 90 days, indicating active trading activity and ongoing AI monitoring

Latest PCK Signals
17/06/2026	SELL
18/05/2026	SELL
17/05/2026	SELL
PCK Share Price
Current Price	$0.100
52 Week High	$0.830
52 Week Low:	$0.096
Trading at (% of 52 Week High)	12.05%

Business Overview

PainChek Ltd (ASX: PCK) is a healthcare technology company that develops and commercializes pain assessment tools using artificial intelligence. Its flagship product uses facial recognition software to help identify and measure pain levels, primarily for people who have difficulty communicating, such as those with dementia. The company aims to improve pain management and clinical outcomes in healthcare settings.

ASX Sector Overview

Sector:   Health Care Equipment & Services

The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.

Latest AI Recommendation

The SELL recommendation for PAINCHEK LTD (PCK) is supported by weak price performance and potential liquidity concerns at the current low price level. However, the confidence is moderated by limited available market data and potential volatility in micro-cap stocks.

Latest  PAINCHEK LTD(PCK)   News